These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16928264)

  • 1. Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.
    Yang HJ; Liu VW; Wang Y; Tsang PC; Ngan HY
    BMC Cancer; 2006 Aug; 6():212. PubMed ID: 16928264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
    Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
    World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
    Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
    BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Promoter hypermethylation gene patterns in gynecological tumors].
    Leal Rojas P; Anabalón Rodríguez L; García Muñoz P; Tapia Escalona O; Guzmán González P; Araya Orostica JC; Villaseca Hernández M; Roa Strauch JC
    Med Clin (Barc); 2009 Mar; 132(10):371-6. PubMed ID: 19268989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients.
    Yang HJ; Liu VW; Wang Y; Chan KY; Tsang PC; Khoo US; Cheung AN; Ngan HY
    Gynecol Oncol; 2004 May; 93(2):435-40. PubMed ID: 15099958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients.
    Bodoor K; Haddad Y; Alkhateeb A; Al-Abbadi A; Dowairi M; Magableh A; Bsoul N; Ghabkari A
    Asian Pac J Cancer Prev; 2014; 15(1):75-84. PubMed ID: 24528084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
    Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
    BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
    Esteller M
    Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
    Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant gene promoter methylation in plasma cell dyscrasias.
    Martin P; Garcia-Cosio M; Santon A; Bellas C
    Exp Mol Pathol; 2008 Jun; 84(3):256-61. PubMed ID: 18410922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
    Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprimo as a potential biomarker for early detection in gastric cancer.
    Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
    Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.
    Kang S; Kim JW; Kang GH; Lee S; Park NH; Song YS; Park SY; Kang SB; Lee HP
    Int J Cancer; 2006 May; 118(9):2168-71. PubMed ID: 16331610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.
    Kontic M; Stojsic J; Jovanovic D; Bunjevacki V; Ognjanovic S; Kuriger J; Puumala S; Nelson HH
    Clin Lung Cancer; 2012 Jul; 13(4):297-303. PubMed ID: 22169480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
    Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
    Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.
    Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB
    Tumori; 2010; 96(5):726-33. PubMed ID: 21302620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
    Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization.
    Di Domenico M; Santoro A; Ricciardi C; Iaccarino M; Iaccarino S; Freda M; Feola A; Sanguedolce F; Losito S; Pasquali D; Di Spiezio Sardo A; Bifulco G; Nappi C; Bufo P; Guida M; De Rosa G; Abbruzzese A; Caraglia M; Pannone G
    Cancer Biol Ther; 2011 Sep; 12(5):447-57. PubMed ID: 21709441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.